Alfredo García‐Arieta

Author

Agencia Española de Medicamentos y Productos Sanitarios ORCID

Also Known As

A García-Arieta, A Garcı́a-Arieta, A. Garcia Arieta, A. Garcia-Arieta, A. García-Arieta, Alfredo GARCÍA-ARIETA, Alfredo Garcia Arieta, Alfredo Garcia-Arieta, Alfredo Garcia‐Arieta, Alfredo García Arieta

107

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Agencia Española de Medicamentos y Productos Sanitarios Universidad Complutense de Madrid Universitat de Miguel Hernández d'Elx Universitat de València Health Canada

About

Alfredo García‐Arieta is an author at Agencia Española de Medicamentos y Productos Sanitarios specializing in medicine, pharmacology, and drug analysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	531
2	Engineering	6	6	123
3	Biochemistry	3	3	58
4	Allergy	1	1	30
5	Biomedical Engineering	1	1	30

Alfredo García‐Arieta

Publications

919

Citations

H-Index

Page 1

	Year	Citations
<i>In silico</i> prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen Yasuhiro Tsume, Peter Langguth, Alfredo García‐Arieta, Biopharmaceutics & Drug Disposition	2012	104
Interactions between active pharmaceutical ingredients and excipients affecting bioavailability: Impact on bioequivalence Alfredo García‐Arieta European Journal of Pharmaceutical Sciences Pharmaceutical ScienceExcipientsMedicineBioequivalenceActive Ingredient	2014	97
Investigation on the Possibility of Biowaivers for Ibuprofen Covadonga Álvarez, Ignacio Núñez, Juan J. Torrado, Journal of Pharmaceutical Sciences PharmacologyPharmacotherapyMedicinePharmaceutical Research	2011	70
Regulatory Considerations for Approval of Generic Inhalation Drug Products in the US, EU, Brazil, China, and India Sau L. Lee, Bhawana Saluja, Alfredo García‐Arieta, The AAPS Journal Drug SafetyAsthmaRegulatory ApprovalHealth PolicyBioequivalence	2015	62
In Vitro Dissolution as a Tool for Formulation Selection: Telmisartan Two-Step IVIVC Alejandro Ruiz-Picazo, Mayte Martínez-Martínez, Sarin Colón-Useche, Molecular Pharmaceutics	2018	34
Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool Andrés Figueroa-Campos, Bárbara Sánchez-Dengra, Virginia Merino, Pharmaceutics	2020	34
Spray-Dried Powders as Nasal Absorption Enhancers of Cyanocobalamin. Alfredo García‐Arieta, Santiago Torrado, Luis Goya, Biological and Pharmaceutical Bulletin Pharmaceutical ScienceHigher BioavailabilityAllergyBioanalysisPharmacology	2001	30
Investigating the Discriminatory Power of BCS-Biowaiver <i>in Vitro</i> Methodology to Detect Bioavailability Differences between Immediate Release Products Containing a Class I Drug Sarin Colón-Useche, Isabel González‐Álvarez, Víctor Mangas‐Sanjuan, Molecular Pharmaceutics Pharmaceutical ScienceEngineeringSlower Dissolution RateBiomedical EngineeringZolpidem Formulations	2015	30
Bioequivalence between generic tacrolimus products marketed in Spain by adjusted indirect comparison Marta Herránz, Susana Morales‐Alcelay, Ma Teresa Corredera-Hernández, European Journal of Clinical Pharmacology BioequivalencePharmacologyGeneric Tacrolimus ProductsMedicineAdjusted Indirect Comparison	2012	24
High-Fat Breakfast Increases Bioavailability of Albendazole Compared to Low-Fat Breakfast: Single-Dose Study in Healthy Subjects Dolores Ochoa, Miriam Saiz‐Rodríguez, Esperanza González‐Rojano, Frontiers in Pharmacology	2021	24

Page 1